Study: Strontium Drug Slows Osteoporosis

A drug based on the element strontium slows the development of brittle bone disease and cuts the risk of spine fractures in half among high-risk patients, researchers said on Wednesday. The drug, strontium ranelate, appears to have a unique way of slowing the natural process of bone destruction and rejuvenating the process of bone rebuilding. In osteoporosis, the destruction process is faster than the renewal process, which in turn weakens the bones and often leads to breaks.